HOSPITAL UNIVERSITARIO QUIRÓNSALUD MADRID
Departamento
Dana–Farber Cancer Institute
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Dana–Farber Cancer Institute (3)
2024
-
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes
Nature Genetics, Vol. 56, Núm. 9, pp. 1878-1889
2017
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97
2002
-
Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: A randomized trial
Journal of the National Cancer Institute, Vol. 94, Núm. 14, pp. 1054-1065